These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23077850)

  • 41. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis.
    de Greeff SC; de Melker HE; Westerhof A; Schellekens JF; Mooi FR; van Boven M
    Epidemiology; 2012 Nov; 23(6):852-60. PubMed ID: 23018969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A countywide outbreak of pertussis: initial transmission in a high school weight room with subsequent substantial impact on adolescents and adults.
    Sotir MJ; Cappozzo DL; Warshauer DM; Schmidt CE; Monson TA; Berg JL; Zastrow JA; Gabor GW; Davis JP
    Arch Pediatr Adolesc Med; 2008 Jan; 162(1):79-85. PubMed ID: 18180417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Using computer simulations to compare pertussis vaccination strategies in Australia.
    Hethcote HW; Horby P; McIntyre P
    Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands.
    Westra TA; de Vries R; Tamminga JJ; Sauboin CJ; Postma MJ
    Clin Ther; 2010 Aug; 32(8):1479-95. PubMed ID: 20728761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance.
    Nilsson L; Lepp T; von Segebaden K; Hallander H; Gustafsson L
    Vaccine; 2012 May; 30(21):3239-47. PubMed ID: 22094282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993.
    Wortis N; Strebel PM; Wharton M; Bardenheier B; Hardy IR
    Pediatrics; 1996 May; 97(5):607-12. PubMed ID: 8628595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pertussis (whooping cough) epidemiology in Waikato, New Zealand: 2000-2009.
    Wall R; Bell A; Theobald J
    N Z Med J; 2011 Apr; 124(1332):52-61. PubMed ID: 21747424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
    Li WC; Wu TZ; Huang YC; Huang LM
    Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pertussis in adults: possible use of booster doses for control.
    Hewlett EL
    Tokai J Exp Clin Med; 1988; 13 Suppl():125-8. PubMed ID: 3078801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
    Girard DZ
    Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adolescent and adult pertussis: disease burden and prevention.
    Edwards K; Freeman DM
    Curr Opin Pediatr; 2006 Feb; 18(1):77-80. PubMed ID: 16470167
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pertussis--United States, 1997-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(4):73-6. PubMed ID: 11837909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.
    Binkin NJ; Salmaso S; Tozzi AE; Scuderi G; Greco D; Greco D
    Pediatr Infect Dis J; 1992 Aug; 11(8):653-61. PubMed ID: 1523078
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis].
    Lutyńska A; Wiatrzyk A; Mosiej E; Zawadka M
    Przegl Epidemiol; 2011; 65(1):45-50. PubMed ID: 21735835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Acellular pertussis vaccine (Pa)].
    Magdzik W
    Przegl Epidemiol; 1995; 49(3):325-9. PubMed ID: 7491431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management and prevention of pertussis infection in neonates.
    Berti E; Venturini E; Galli L; de Martino M; Chiappini E
    Expert Rev Anti Infect Ther; 2014 Dec; 12(12):1515-31. PubMed ID: 25371322
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adolescent and adult pertussis vaccination: computer simulations of five new strategies.
    Van Rie A; Hethcote HW
    Vaccine; 2004 Aug; 22(23-24):3154-65. PubMed ID: 15297068
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infants hospitalised with pertussis: estimating the true disease burden.
    Somerville RL; Grant CC; Grimwood K; Murdoch D; Graham D; Jackson P; Meates-Dennis M; Nicholson R; Purvis D
    J Paediatr Child Health; 2007 Sep; 43(9):617-22. PubMed ID: 17608654
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of an accelerated immunisation schedule on pertussis in England and Wales.
    White JM; Fairley CK; Owen D; Matthews RC; Miller E
    Commun Dis Rep CDR Rev; 1996 May; 6(6):R86-91. PubMed ID: 8664929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.